Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGDR2 | Q9Y5Y4 | 3/20 | 0.45 |
| ▸ | PTGER1 | P34995 | 3/20 | 0.42 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.41 |
| ▸ | MRGPRX4 | Q96LA9 | 2/20 | 0.40 |
| ▸ | PPARD | Q03181 | 5/20 | 0.40 |
| ▸ | PPARA | Q07869 | 3/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.37 |
| ▸ | PPARG | P37231 | 2/20 | 0.37 |
| ▸ | PDE5A | O76074 | 2/20 | 0.36 |
| ▸ | PDE6D | O43924 | 1/20 | 0.36 |
| ▸ | PDE6A | P16499 | 1/20 | 0.36 |
| ▸ | PDE6G | P18545 | 1/20 | 0.36 |
| ▸ | PDE6B | P35913 | 1/20 | 0.36 |
| ▸ | PDE6C | P51160 | 1/20 | 0.36 |
| ▸ | PDE6H | Q13956 | 1/20 | 0.36 |
| ▸ | MAOB | P27338 | 1/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4155948 | 0.88 | PTGER1 (0.57) | PTGER1CYP2C9MRGPRX4MAOBCYP3A4 | |
| SCHEMBL4147278 | 0.87 | MAPT (0.39) | PTGER1CYP2C9MRGPRX4MAPTPDE5A | |
| SCHEMBL4159453 | 0.85 | PTGER1 (0.48) | PTGER1CYP2C9MRGPRX4PPARDPPARA | |
| SCHEMBL4444095 | 0.84 | PTGER1 (0.55) | PTGER1CYP2C9MRGPRX4CYP3A4CYP2C19 | |
| SCHEMBL4162804 | 0.81 | PTGER1 (0.49) | PTGDR2PTGER1CYP2C9MRGPRX4MAOB | |
| SCHEMBL4168478 | 0.81 | PTGER1 (0.48) | PTGER1CYP2C9MRGPRX4PPARDPPARA | |
| SCHEMBL4154448 | 0.80 | MRGPRX4 (0.44) | PTGER1CYP2C9MRGPRX4PPARDMAPT | |
| SCHEMBL4150131 | 0.79 | PTGER1 (0.59) | PTGER1CYP2C9PPARDMAOB | |
| SCHEMBL13697347 | 0.79 | PTGER1 (0.49) | PTGER1CYP2C9PPARDPPARAMAOB | |
| SCHEMBL13697453 | 0.79 | PTGER1 (0.57) | PTGER1CYP2C9MRGPRX4PPARDPPARA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090227591-A1 | Cyclopentene compounds | GLAXO GROUP LIMITED (GB) | 2009-09-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090227591-A1 | Cyclopentene compounds | C1R, CYP1B1, ADORA2B | PTGDR2 231/4885PTGER1 246/4885CYP2C9 5/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.